Investor Presentaiton
CO
6
INOVIO Technology - Powering Potent Antigen Specific
Immune Responses
1. Identify diverse
strains/variants of a
target virus or cancer
Antigen Y
Strain 2
INOVIO DNA medicines power a patient's immune system to generate
functional antibodies and killer T cells in vivo to fight cancer and infectious disease
2. Assess gene sequence
of selected antigen(s) from
chosen strains/variants of
the virus or cancer
3. Create optimal
Consensus Sequence for
the selected antigen
4. Insert SynCon sequence for each
selected antigen into a separate
precisely designed plasmid
5. Manufacture DNA medicine
and deliver into muscle (IM) or skin (ID) using
CELLECTRAⓇ proprietary smart device
Antigen Y
Antigen Y
Strain X
Strain 1
6. Protective antibodies and killer
T cells produced by immune
system against diverse strains of
a virus or cancer
Sequence 1
EMEKIVLLFAIV...SL
XX
Sequence 2
Sequence X
Consensus
AMESIVLLFAIV...SL
DNA
Medicine
DNA
Medicine
AMEKIVILLFAIV...SK
AMEKIVILLFAIV...SL
INOVIO
IM
ID
INOVIO
POWERING DNA MEDICINESView entire presentation